Metraipolis › archive › dc_80439cbd8a9b
Redox therapy for neuropsychiatric disorders: Molecular mechanisms and biomarker development — Europe PMC PMID:41706850
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41706850
- DOI
- 10.1126/sciadv.aea9014
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T16:14:51.100Z
- SHA-256 of the archived text
88a92c353c39f840b5bfe06f5c177769d11b456f9a51d3e3b8d89dcd86e437e8- Stable URL of this page
https://metraipolis.com/documento/dc_80439cbd8a9b
How to cite
Redox therapy for neuropsychiatric disorders: Molecular mechanisms and biomarker development — Europe PMC PMID:41706850 — Europe PMC (en), https://europepmc.org/article/MED/41706850 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80439cbd8a9b (Metraipolis archive dc_80439cbd8a9b, sha256 88a92c353c39f840b5bfe06f5c177769d11b456f9a51d3e3b8d89dcd86e437e8)
BibTeX
@misc{dc80439cbd8a9b,
title = {Redox therapy for neuropsychiatric disorders: Molecular mechanisms and biomarker development — Europe PMC PMID:41706850},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41706850},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80439cbd8a9b; sha256 88a92c353c39f840b5bfe06f5c177769d11b456f9a51d3e3b8d89dcd86e437e8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41706850. Agents can read the archived copy with the MCP tool read_document.